263 related articles for article (PubMed ID: 15888562)
1. Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans.
Bankir L; Fernandes S; Bardoux P; Bouby N; Bichet DG
J Am Soc Nephrol; 2005 Jul; 16(7):1920-8. PubMed ID: 15888562
[TBL] [Abstract][Full Text] [Related]
2. Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2.
Joo KW; Jeon US; Kim GH; Park J; Oh YK; Kim YS; Ahn C; Kim S; Kim SY; Lee JS; Han JS
Nephrol Dial Transplant; 2004 Oct; 19(10):2480-6. PubMed ID: 15280526
[TBL] [Abstract][Full Text] [Related]
3. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
Brink HS; Derkx FH; Boomsma F; Brommer EJ; Schalekamp MA
Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension?
Bankir L; Bichet DG; Bouby N
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F917-28. PubMed ID: 20826569
[TBL] [Abstract][Full Text] [Related]
5. Chronic dDAVP infusion in rats decreases the expression of P2Y2 receptor in inner medulla and P2Y2 receptor-mediated PGE2 release by IMCD.
Sun R; Miller RL; Hemmert AC; Zhang P; Shi H; Nelson RD; Kishore BK
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F768-76. PubMed ID: 15914777
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of aquaporin-2 in patients with diabetes insipidus.
Kanno K; Sasaki S; Hirata Y; Ishikawa S; Fushimi K; Nakanishi S; Bichet DG; Marumo F
N Engl J Med; 1995 Jun; 332(23):1540-5. PubMed ID: 7537863
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of arginine vasopressin suppression of ovine fetal lung fluid secretion: lack of V2-receptor effect.
Albuquerque CA; Nijland MJ; Ross MG
J Matern Fetal Med; 1998; 7(4):177-82. PubMed ID: 9730483
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
[TBL] [Abstract][Full Text] [Related]
9. Antinatriuretic effect of vasopressin in humans is amiloride sensitive, thus ENaC dependent.
Blanchard A; Frank M; Wuerzner G; Peyrard S; Bankir L; Jeunemaitre X; Azizi M
Clin J Am Soc Nephrol; 2011 Apr; 6(4):753-9. PubMed ID: 21233458
[TBL] [Abstract][Full Text] [Related]
10. Vasopressin receptor mutations causing nephrogenic diabetes insipidus.
Bichet DG; Turner M; Morin D
Proc Assoc Am Physicians; 1998; 110(5):387-94. PubMed ID: 9756088
[TBL] [Abstract][Full Text] [Related]
11. [Pathological aspects of water transport in the collecting ducts].
Bichet DG
Nephrologie; 1996; 17(7):417-22. PubMed ID: 9019668
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II AT1 receptor blockade decreases vasopressin-induced water reabsorption and AQP2 levels in NaCl-restricted rats.
Kwon TH; Nielsen J; Knepper MA; Frøkiaer J; Nielsen S
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F673-84. PubMed ID: 15585668
[TBL] [Abstract][Full Text] [Related]
13. Nephrogenic diabetes insipidus.
Bichet DG
Adv Chronic Kidney Dis; 2006 Apr; 13(2):96-104. PubMed ID: 16580609
[TBL] [Abstract][Full Text] [Related]
14. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity.
Li Y; Shaw S; Kamsteeg EJ; Vandewalle A; Deen PM
J Am Soc Nephrol; 2006 Apr; 17(4):1063-72. PubMed ID: 16495377
[TBL] [Abstract][Full Text] [Related]
15. Chronic activation of vasopressin-2 receptors induces hypertension in Liddle mice by promoting Na
Stockand JD; Mironova EV; Xiang H; Soares AG; Contreras J; McCormick JA; Gurley SB; Pao AC
Am J Physiol Renal Physiol; 2022 Oct; 323(4):F468-F478. PubMed ID: 35900342
[TBL] [Abstract][Full Text] [Related]
16. Lack of elevation of urinary albumin excretion among patients with chronic syndromes of inappropriate antidiuresis.
Vandergheynst F; Decaux G
Nephrol Dial Transplant; 2008 Jul; 23(7):2399-401. PubMed ID: 18400823
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
Walker LA; Frölich JC
J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
[TBL] [Abstract][Full Text] [Related]
18. Effects of the vasopressin agonist terlipressin on plasma cAMP and ENaC excretion in the urine in patients with cirrhosis and water retention.
Krag A; Pedersen EB; Møller S; Bendtsen F
Scand J Clin Lab Invest; 2011 Apr; 71(2):112-6. PubMed ID: 21080762
[TBL] [Abstract][Full Text] [Related]
19. Lack of responsiveness to 1-desamino-D arginin vasopressin (desmopressin) in male patients with nephrogenic syndrome of inappropriate antidiuresis: from bench to bedside.
Vandergheynst F; Pradier O; Beukinga I; Kornreich A; Vassart G; Decaux G
Eur J Clin Invest; 2012 Mar; 42(3):254-9. PubMed ID: 21834801
[TBL] [Abstract][Full Text] [Related]
20. Collecting duct-specific knockout of endothelin-1 alters vasopressin regulation of urine osmolality.
Ge Y; Ahn D; Stricklett PK; Hughes AK; Yanagisawa M; Verbalis JG; Kohan DE
Am J Physiol Renal Physiol; 2005 May; 288(5):F912-20. PubMed ID: 15632412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
